KRINGLE PHARMA
LIVE

Serial Number

50024662

Owner

KRINGLE PHARMA, INC.

Attorney

Kumiko Ide

Filing Date

Jul 31, 2026

Add to watchlist:

No watchlists yet
View on USPTO

KRINGLE PHARMA Trademark

Serial Number: 50024662

KRINGLE PHARMA is a trademark filed by KRINGLE PHARMA, INC. on July 31, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

KRINGLE PHARMA, INC. (2 trademarks)

4- 3-51 Nakanoshima, Kita-ku
Osaka-shi, Osaka 530-0005 , JP

Entity Type: 03

Trademark Details

Filing Date

July 31, 2026

Registration Date

Not Registered

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of liver diseases, renal disease, nerve system diseases, skin diseases, cardiovascular diseases, cancer; pharmaceutical preparations acting on the peripheral nervous system; cardiovascular treatment preparations; capillary stabilizers, namely, pharmaceutical preparations for stabilizing capillaries; cerebral hemorrhage prophylactic preparations; pharmaceutical preparations acting on respiratory organs for treating respiratory illnesses and conditions; pharmaceutical preparations acting on digestive organs for treating ulcers and digestive conditions; pharmaceutical preparations for dental purposes for treating and preventing gingivostomatitis, alveolar abscess, and alveoloclasia; pharmaceutical preparations acting on uro-genital and anal organs for treating urinary and anal gland related illnesses and conditions; medicated skin care preparations; astringents for medical purposes; anti-inflammatory agents; saccharide preparations for treating skin diseases, namely, skin ulcer, injury, burn, scleroderma, dematitis, erythroderma, keratosis, dyschromatosis, and lupus erhthematosus; hemostatics for medical purposes; pharmaceutical preparations affecting metabolism; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for treating physically caused lesions; radiation sickness treating drugs; pharmaceutical preparations for treating chemically caused disorders, namely, for treating chemical burns, side effects of anticancer drugs, and side effects of immunosuppresants; biological preparations for medical purposes, namely, biological tissue grafts

Testing, inspection or research of pharmaceuticals and genetics; medical research; consultancy and providing testing, inspection and research information services in the field of testing, inspection or research of pharmaceuticals and genetics; consultancy and providing research information services in the field of medical research; providing medical research and scientific research information and advice in the fields of pharmaceuticals and genetics

Filing History

APPLICATION FILING RECEIPT MAILED
Jul 31, 2026 MAFR
NEW APPLICATION ENTERED
Jul 31, 2026 NWAP